Acta crystallographica. Section D, Structural biologyDrug DiscoveryCrystallographyX-RaySynchrotronsJapan
A new macromolecular crystallography endstation at NanoTerasu for accelerating structural biology and drug discovery.
Yusuke Yamada, Keisuke Sakurai, Akiya Fukuda, Hiroyuki Yamane, Tadashi Hatano, Tetsuya Nakamura, Go Ueno, Takuya Masunaga, Masaki Yamamoto, Eriko Nango
Published: 202610.1107/S2059798325011234
Abstract
Since the fiscal year 2022, `Support Program for Life Science and Drug Discovery Research (BINDS Phase II)', funded by the Japan Agency for Medical Research and Development (AMED), has been supporting structural analysis research in Japan, promoting…
Preview only. Read the full abstract at the source